Portfolio company
1910 Genetics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops AI-driven drug discovery platforms and automated wet labs to provide pharmaceutical firms with small molecule and protein therapeutic development services.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Generate Biomedicine
This company develops protein-based therapeutics using a generative artificial intelligence platform for pharmaceutical partners and biotechnology firms.
Genesis Molecular AI
The company develops an artificial intelligence platform for molecular drug discovery to assist pharmaceutical firms in designing and optimising small molecule medicines.
Ten63 Therapeutics
This company develops small-molecule drugs for pharmaceutical partners and patients using a generative artificial intelligence and physics-based chemistry platform to treat undruggable protein targets.
Drug Discovery
This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.
TANDEMAI
This company provides a platform combining artificial intelligence and physics-based computation with wet lab services for biotech and pharmaceutical drug discovery.
310.ai
This company develops generative artificial intelligence models to design novel proteins and biomolecules for pharmaceutical and biotechnology organisations.
AI-enabled drug design
This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.
Relation Therapeutics
This biotechnology firm develops an artificial intelligence platform to identify and validate therapeutic drug targets for pharmaceutical companies and research partners.